19 reports of this reaction
3.5% of all ESMOLOL HYDROCHLORIDE reports
#3 most reported adverse reaction
HYPOTENSION is the #3 most commonly reported adverse reaction for ESMOLOL HYDROCHLORIDE, manufactured by Baxter Healthcare Corporation. There are 19 FDA adverse event reports linking ESMOLOL HYDROCHLORIDE to HYPOTENSION. This represents approximately 3.5% of all 539 adverse event reports for this drug.
Patients taking ESMOLOL HYDROCHLORIDE who experience hypotension should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOTENSION is moderately reported among ESMOLOL HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to hypotension, the following adverse reactions have been reported for ESMOLOL HYDROCHLORIDE:
The following drugs have also been linked to hypotension in FDA adverse event reports:
HYPOTENSION has been reported as an adverse event in 19 FDA reports for ESMOLOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOTENSION accounts for approximately 3.5% of all adverse event reports for ESMOLOL HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience hypotension while taking ESMOLOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.